Accelerate Protein Engineering with AI-Driven Design-Build-Test-Learn (DBTL)

AI-Accelerated Design-Build-Test-Learn (DBTL) for Protein & Enzyme Engineering

Engineering high-performance proteins rarely succeeds in a single design cycle.

Modern protein engineering relies on iterative Design-Build-Test-Learn (DBTL) workflows that continuously improve enzyme performance through data-driven optimization.

Whether developing industrial enzymes, therapeutic proteins, biosensors, or synthetic biology platforms, organizations seek to reduce development time while improving the probability of technical success.

Neoncorte Bio combines AI-guided protein engineering with structured DBTL workflows to accelerate the development of custom proteins and enzymes tailored to specific commercial and research objectives.

What is the Design-Build-Test-Learn (DBTL) Cycle?

The DBTL framework is an iterative engineering process used throughout synthetic biology and industrial biotechnology.
 dbtl protein engineering with design build test learn cycle Neoncorte Bio
  • Design

    Computational analysis and AI-guided sequence design identify promising protein variants based on project objectives such as catalytic activity, stability, specificity, or manufacturability.
  • Build

    Selected variants are prepared for experimental evaluation through molecular biology and protein production workflows.
  • Test

    Engineered proteins are experimentally characterized using assays relevant to the desired performance metrics, such as activity, stability, selectivity, expression, or substrate specificity.
  • Learn

    Experimental results are analyzed to refine computational models and guide the next generation of protein variants, continuously improving engineering efficiency.
 dbtl protein engineering with design build test learn cycle Neoncorte Bio

How AI Improves the DBTL Cycle

Traditional protein engineering often requires evaluating thousands of variants through trial-and-error experimentation.
Neoncorte Bio applies AI-guided protein engineering to prioritize the most promising candidates before laboratory testing, helping to:
  • Reduce unnecessary experimental iterations
  • Focus resources on high-value variants
  • Identify beneficial mutations more efficiently
  • Improve prediction of protein behavior
  • Accelerate optimization cycles
By integrating computational design with experimental feedback, each DBTL iteration becomes increasingly informative.
protein engineering with design build test learn dbtl cycle Neoncorte Bio

Applications

  • Industrial Enzyme Engineering
    Optimize catalytic performance, stability, substrate specificity, and manufacturability for commercial enzyme platforms.
    Benefit: Faster development of industrially relevant biocatalysts.
  • Pharmaceutical Protein Engineering
    Support optimization of therapeutic and research proteins during early-stage development.
    Benefit: More efficient lead optimization workflows.
  • Synthetic Biology
    Develop proteins for engineered biological systems requiring iterative performance improvement.
    Benefit: Accelerated platform development.
  • Specialty Chemical Biocatalysis
    Engineer enzymes for selective and scalable manufacturing processes.
    Benefit: Reduced development timelines and improved process economics.

What Neoncorte Bio Delivers

  • AI-guided protein design
  • Custom DBTL workflow development
  • Sequence optimization strategies
  • Protein engineering consulting
  • Candidate prioritization
  • Experimental planning support
  • Fermentation-ready enzyme candidates
  • Confidential B2B development partnerships

Who We Work With

  • Industrial biotechnology companies
  • Synthetic biology startups
  • Pharmaceutical companies
  • CDMOs and CROs
  • Enzyme manufacturers
  • Agricultural biotechnology firms
  • Food ingredient companies
  • Specialty chemical manufacturers
Frequently Asked Questions (FAQs)

Neoncorte Bio

Where AI Meets Biotechnology
Neoncorte Bio is at the forefront of the convergence between artificial intelligence and enzyme engineering. Our team comprises experts in computational biology, bioinformatics, and machine learning, all driven by a mission to accelerate innovation in enzyme design. By leveraging our advanced AI models, we provide unparalleled solutions that enhance efficiency, reduce costs, and push the boundaries of what's possible in enzyme engineering

Proud Member of Leading Global AI Programs

Neoncorte Bio is part of the NVIDIA Inception and Nebius for Startups programs — two of the world’s leading ecosystems for high-performance AI innovation. These partnerships strengthen our ability to deliver next-generation AI-driven protein, enzyme, and aptamer engineering.
  • NVIDIA Inception Neoncorte Bio AI life sciences company
    As a member of NVIDIA Inception, Neoncorte Bio gains access to cutting-edge GPU technologies, expert guidance, and a global AI ecosystem that supports companies from prototype to production. The program empowers us to explore new AI opportunities and build high-performance biological design pipelines powered by NVIDIA’s world-class platform.
  • Nebius AI life sciences Neoncorte Bio
    Through Nebius for Startups, we gain access to high-performance compute infrastructure optimized for large-scale AI workloads, along with hands-on technical guidance and a strong community of innovative AI companies. Nebius enables us to train and deploy complex biological models more efficiently — accelerating enzyme, protein, and aptamer design while supporting rapid scaling of our R&D pipelines.
Publications
Scientific Publication of Neoncorte Bio Team
  • Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5′-3′ exonuclease activity, effective deoxyuracil incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates.
  • The transcriptomic data are being frequently used in the research of biomarker genes of different diseases and biological states. The most common tasks there are the data harmonization and treatment outcome prediction. Both of them can be addressed via the style transfer approach. Either technical factors or any biological details about the samples which we would like to control (gender, biological state, treatment, etc.) can be used as style components.
  • List of all Neoncorte Bio publications dedicated to Molecular Biology, Biotechnology, Artificial Intelligence and Artificial Neural Networks, published mostly by Nikolay Russkikh, CEO of Neoncorte Bio

Our Expertise in Action
With extensive experience in AI applications and software engineering tailored to the life sciences, we specialize in solving complex challenges and delivering innovative solutions for our customers. Our work demonstrates a deep understanding of cutting-edge technologies and their application in the real world.
Here are examples of the types of projects we have successfully delivered:
  • Automated NGS Data Analysis:
    Designed a production-grade solution for the automated processing, annotation, and analysis of Next-Generation Sequencing (NGS) data.
  • Single-Cell Data Integration:
    Built state-of-the-art tools for integrating multimodal single-cell data, achieving recognition for technical excellence.
  • Metagenomic Classification Algorithms:
    Developed advanced methods for classifying sequencing reads in metagenomics research.
  • High-Throughput Image Processing Pipelines:
    Engineered an efficient pipeline to process millions of sequencing images with exceptional accuracy.
  • Cell Counting via AI:
    Created a computer vision solution for precise cell counting in microphotography images, streamlining data analysis.
Get in touch with our team
Phone: +1-503-754-3958
Email: contact@neoncorte.com